Clinical Trials Logo

Recurrent GBM clinical trials

View clinical trials related to Recurrent GBM.

Filter by:
  • None
  • Page 1

NCT ID: NCT03068650 No longer available - Recurrent GBM Clinical Trials

Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut

Start date: n/a
Phase: N/A
Study type: Expanded Access

Celldex endeavors to make investigational products available to patients with life-threatening diseases who have exhausted other treatment options and where there is a reasonable expectation of benefit over risk. Requests for expanded access to rindopepimut in patients with EGFRvlll expressing recurrent glioblastoma will be considered.